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determined in approximately 50% of cases [1]. Chlamydia and
Chlamydia-related bacteria may be the agents of some pneu-
monia of unknown etiology. Indeed, C. psittaci and
C. pneumoniae are well-established agents of pneumonia [2],
whereas Parachlamydia acanthamoebae and Simkania negevensis
are considered to be emerging agents of lung infections [3,4].
However, routine cultures fail to detect these strict intracel-
lular Chlamydiales, and broad-range eubacterial 16S rRNA PCRs
(applied to lung biopsy or pleural ﬂuid samples) also fail to
detect Chlamydiales [5]. Moreover, several additional bacteria
belonging to the Chlamydiales order might possibly be involved
in lung infections, including Rhabdochlamydia spp. and Waddlia
spp., as well as new lineages.
To fully investigate the role of all members of the Chlamy-
diales in lung infections, we thus investigated by a pan-Chlamy-
diales PCR oropharyngeal samples taken from a total of 564
patients with moderately severe community-acquired pneu-
monia included in a prospective study [6].
Brieﬂy, DNA was extracted using the QIAamp DNA Mini Kit
(Qiagen, Hilden, Germany). Then we performed in duplicate aw Microbe and New Infect 2015; 8: 164–165
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where [7]. The results of all tests but one were negative. The
positive sample, taken from a 79-year-old Swiss man, showed
the presence of C. psittaci DNA. The patient was hospitalized
for fever and cough. He complained of acute-onset cough,
dyspnea on minimal exertion and fever. His medical history was
notable for cerebrovascular disease, coronary artery disease
and diabetes mellitus. There was no recent travel or docu-
mented exposure to animals. At admission the patient was
disoriented, hypoxemic and febrile (38.3°C), with mild
tachypnea and tachycardia. Chest examination revealed dullness
on percussion and crackles at the left pulmonary base. He
exhibited mild leukocytosis and elevated urea. Consolidation of
the left lower lobe and a small pleural effusion were docu-
mented by chest X-ray.
Intravenous cefuroxime and oral clarithromycin were
administered. His condition rapidly improved, and the patient
was transferred on the tenth day after admission to a rehabil-
itation facility. Two pairs of blood cultures, obtained before the
administration of any antibiotics, remained sterile. Urine was
negative for the presence of Legionella pneumophila and Strep-
tococcus pneumoniae antigens. Normal oropharyngeal ﬂora was
recovered by culture from a sputum sample. Testing for the
presence of C. pneumoniae and Mycoplasma pneumoniae by PCR
on the oropharyngeal swab was also negative.
Contrarily to what we expected, no Chlamydia-related bac-
teria have been detected by the pan-Chlamydiales PCR in the
largest cohort published to date. This contrasts with previous
work by Marrie et al. [8], who identiﬁed two seroconversions
among 255 patients with community-acquired pneumonia
requiring hospitalization (0.8%), and with the study by Casson
et al. [9] documenting DNA of Parachlamydia acanthamoebae in
15% of nasopharyngeal swabs taken from children with a
bronchiolitis. The difference may be due to the different study
populations. Here, only adults with mild and moderate
community-acquired pneumonia were enrolled and immuno-
compromised patients were excluded, whereas in previous
studies P. acanthamoebae was mainly documented among
immunosuppressed patients [8,10] and children [7,9]. The
absence of S. negevensis DNA argues against a pathogenic role
of Simkania, a still-controversial question [2,3]. On the other
hand, the documented C. psittaci infection underlines the
importance of a complete diagnostic assessment, including
C. psittaci, even in absence of history of exposure to birds.
These data, taken together with the ﬁndings of our study,
demonstrate that outside speciﬁc local conditions that may lead
to cases clusters or outbreaks, different members of the Chla-
mydiales order, including C. pneumoniae, are not common
agents of community-acquired pneumonia [11].European Society of Clinical Microbiology and Infectious Diseases
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